A new paradigm for personalized prophylaxis for patients with severe haemophilia A

AIM: For patients with severe haemophilia A, guidelines recommend prophylactic treatment with FVIII, with dose calculations targeting a predetermined FVIII trough level. However, this pharmacokinetic (PK) approach is suboptimal, with some patients experiencing breakthrough bleeds. We aimed to improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Delavenne, Xavier, Ollier, Edouard, Lienhart, Anne, Dargaud, Yesim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154752/
https://www.ncbi.nlm.nih.gov/pubmed/32100950
http://dx.doi.org/10.1111/hae.13935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154752/
https://www.ncbi.nlm.nih.gov/pubmed/32100950
http://dx.doi.org/10.1111/hae.13935

Ejemplares similares